| 1/21/2026 | SP | New Issue: GS Finance prices $8.03 million autocallable buffered basket-linked notes on stocks
|
| 12/15/2025 | SP | New Issue: Morgan Stanley prices $1 million buffered jump securities linked to stock basket
|
| 12/10/2025 | SP | New Issue: Morgan Stanley prices $1 million buffered jump autocalls on stock basket
|
| 11/30/2025 | SP | New Issue: HSBC sells $2.04 million autocallable contingent income barrier notes on Regeneron
|
| 9/9/2025 | SP | New Issue: HSBC prices $4.28 million 10.7% contingent income barrier autocalls on Regeneron
|
| 7/23/2025 | SP | New Issue: HSBC sells $5.01 million 12.81% autocallable contingent income barrier notes on Regeneron
|
| 5/19/2025 | SP | New Issue: UBS prices $2.51 million trigger autocallable contingent yield notes linked to Regeneron
|
| 2/21/2025 | SP | New Issue: Citigroup prices $1.22 million autocallable contingent coupon notes linked to three stocks
|
| 1/29/2025 | SP | New Issue: BofA prices $1.1 million contingent income autocallable yield notes with memory on stocks
|
| 1/8/2025 | SPSW | 2024 sets record in sales of structured notes with $113 billion amid bullish stock market
|
| 8/22/2024 | SP | New Issue: JPMorgan prices $1.43 million return notes linked to basket of 20 stocks
|
| 6/27/2024 | CVSP | New Issue: GS Finance sells $365 million 1.25% fixed-rate equity-linked notes on Regeneron
|
| 5/15/2024 | SPSW | Structured products issuance $947 million for week; $401 million Eli Lilly deal eyed
|
| 3/13/2024 | SPSW | Structured notes tally for week $494 million; stocks, ETFs strong amid low volatility
|
| 2/28/2024 | SPSW | Weekly structured notes tally $292 million amid Nvidia-induced stock market mania
|
| 2/21/2024 | SPSW | Structured products tally $541 million for week; big $305 million Regeneron-linked deal eyed
|
| 2/16/2024 | CVSP | New Issue: Morgan Stanley sells $275 million cash-settled equity-linked notes on Regeneron
|
| 6/28/2023 | SP | New Issue: JPMorgan prices $1.58 million return notes linked to basket of 20 stocks
|
| 3/26/2021 | SP | New Issue: JPMorgan prices $525,000 callable contingent interest notes on Regeneron
|
| 3/23/2021 | SP | New Issue: JPMorgan prices $3.42 million callable contingent interest notes on Regeneron
|
| 1/26/2021 | SP | New Issue: UBS prices $100,000 buffered return optimization securities linked to Regeneron
|
| 12/29/2020 | SP | New Issue: GS Finance sells $1.71 million leveraged basket-linked notes on 23 stocks
|
| 12/19/2020 | SP | New Issue: Credit Suisse prices $2.8 million Accelerated Return Equity Securities on stock basket
|
| 12/19/2020 | SP | New Issue: Credit Suisse prices $1.43 million Accelerated Return Equity Securities on stock basket
|
| 11/19/2020 | SP | New Issue: BofA prices $1.17 million contingent income buffered autocalls on stocks
|
| 9/2/2020 | SP | New Issue: Goldman prices $1.2 million leveraged basket-linked notes on 20 stocks
|
| 4/24/2020 | SP | New Issue: Goldman prices $1.73 million leveraged basket-linked notes on 19 stocks
|
| 4/12/2020 | SP | New Issue: JPMorgan prices $1 million digital contingent buffered notes on Regeneron
|
| 2/3/2020 | SP | New Issue: Credit Suisse sells $1.21 million contingent coupon autocallable reverse convertibles on three stocks
|
| 11/20/2019 | SP | New Issue: UBS prices $745,000 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 10/18/2019 | SP | New Issue: UBS prices $100,000 buffered return optimization securities linked to Regeneron Pharmaceuticals
|
| 5/24/2019 | SP | New Issue: Credit Suisse sells $3.59 million contingent coupon autocallable reverse convertibles on Regeneron
|
| 5/16/2019 | SP | New Issue: UBS prices $600,000 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 4/17/2019 | SP | New Issue: UBS prices $176,000 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 3/6/2019 | SP | New Issue: Citigroup sells $500,000 autocallable equity-linked notes on four stocks
|
| 2/14/2019 | SP | Citigroup plans autocallable equity-linked notes tied to four stocks
|
| 10/31/2018 | SP | New Issue: UBS prices $275,000 trigger phoenix autocallables linked to Regeneron
|
| 9/25/2018 | SP | New Issue: UBS prices $136,000 trigger phoenix autocallables linked to Regeneron
|
| 7/10/2018 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Regeneron
|
| 4/9/2018 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Regeneron
|
| 4/6/2018 | SP | New Issue: Credit Suisse sells $1.58 million contingent 10.75% autocall reverse converts on Regeneron
|
| 3/28/2018 | SP | New Issue: Credit Suisse sells $1.53 million contingent coupon autocallable reverse convertibles on Regeneron
|
| 3/12/2018 | SP | New Issue: UBS prices $250,000 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 2/9/2018 | SP | New Issue: Citigroup sells $572,000 autocallable equity-linked notes tied to pharma stocks
|
| 1/23/2018 | SP | New Issue: UBS prices $110,000 trigger phoenix autocallables linked to Regeneron
|
| 1/9/2018 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Regeneron
|
| 1/4/2018 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Regeneron
|
| 12/20/2017 | SP | New Issue: UBS prices $133,000 trigger phoenix autocallables linked to Regeneron
|
| 12/15/2017 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 12/11/2017 | SP | New Issue: UBS prices $395,000 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 12/6/2017 | SP | New Issue: UBS prices $100,000 trigger autocallables linked to Regeneron
|
| 9/27/2017 | SP | New Issue: Credit Suisse prices $500,000 10% autocallable reverse convertibles linked to pharma stocks
|
| 9/1/2017 | SP | New Issue: UBS prices $455,000 trigger phoenix autocallables linked to Regeneron
|
| 7/14/2017 | SP | New Issue: UBS prices $940,000 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 7/14/2017 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 5/26/2017 | SP | New Issue: UBS prices $350,000 trigger phoenix autocallables linked to Regeneron
|
| 5/23/2017 | SP | New Issue: UBS prices $150,000 trigger phoenix autocallables linked to Regeneron
|
| 5/12/2017 | SP | New Issue: UBS prices $560,000 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 5/2/2017 | SP | New Issue: UBS prices $200,000 trigger phoenix autocallables linked to Regeneron
|
| 4/18/2017 | SP | New Issue: Credit Suisse sells $679,000 autocallable yield notes on pharma stocks
|
| 4/5/2017 | SP | New Issue: UBS prices $335,000 trigger phoenix autocallables linked to Regeneron
|
| 3/13/2017 | SP | New Issue: UBS prices $810,000 trigger phoenix autocallables linked to Regeneron
|
| 3/1/2017 | SP | New Issue: UBS prices $200,000 trigger phoenix autocallables linked to Regeneron
|
| 2/15/2017 | SP | New Issue: UBS prices $150,000 trigger phoenix autocallables linked to Regeneron
|
| 1/4/2017 | SP | New Issue: UBS prices $300,000 trigger phoenix autocallables linked to Regeneron
|
| 1/3/2017 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 1/3/2017 | SP | New Issue: UBS prices $205,000 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 12/7/2016 | SP | New Issue: UBS prices $275,000 trigger phoenix autocallables linked to Regeneron
|
| 12/6/2016 | SP | New Issue: UBS prices $150,000 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 11/28/2016 | SP | New Issue: UBS prices $570,000 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 11/4/2016 | SP | New Issue: UBS prices $125,000 trigger phoenix autocallables linked to Regeneron
|
| 10/11/2016 | SP | New Issue: Barclays prices $3.23 million autocallable notes tied to Regeneron
|
| 9/28/2016 | SP | Barclays plans to price autocallable securities linked to Regeneron
|
| 9/20/2016 | SP | New Issue: Barclays sells $3.44 million of phoenix autocallables tied to Regeneron
|
| 9/16/2016 | SP | New Issue: HSBC prices $3 million of AMPS linked to basket of 20 common stocks
|
| 9/13/2016 | SP | Barclays plans to price phoenix autocallable notes tied to Regeneron
|
| 9/8/2016 | SP | HSBC plans 15-month AMPS with cap linked to basket of 20 stocks
|
| 7/19/2016 | SP | New Issue: HSBC prices $1.54 million contingent income autocallables linked to Regeneron
|
| 7/7/2016 | SP | HSBC plans contingent income autocallables linked to Regeneron
|
| 6/14/2016 | SP | New Issue: Citigroup prices $2.14 million contingent coupon autocallables linked to Regeneron
|
| 6/13/2016 | SP | New Issue: RBC prices $1.75 million contingent income autocallables linked to Regeneron
|
| 6/1/2016 | SP | RBC plans contingent income autocallables due 2016 linked to Regeneron
|
| 5/23/2016 | SP | New Issue: Credit Suisse prices $1.82 million contingent coupon autocallables on pharma stocks
|
| 5/18/2016 | SP | Credit Suisse plans contingent coupon autocallable yield notes linked to three stocks
|
| 3/24/2016 | SP | New Issue: Wells Fargo prices $5.23 million of 0.125% notes tied to pharma stocks
|
| 3/22/2016 | SP | Wells Fargo to price 0.125% notes linked to four pharma stocks
|
| 1/14/2016 | SP | New Issue: JPMorgan prices $8.8 million autocallable reverse exchangeables linked to pharma stocks
|
| 1/13/2016 | SP | New Issue: Barclays prices $981,000 contingent income autocallables on Regeneron
|
| 1/7/2016 | SP | Barclays plans contingent income autocallables linked to Regeneron
|
| 1/6/2016 | SP | JPMorgan plans 10% autocallable reverse exchangeables linked to stocks
|
| 7/6/2015 | SP | New Issue: HSBC prices $3.05 million contingent income autocallables on Regeneron
|
| 6/19/2015 | SP | HSBC plans contingent income autocallable notes linked to Regeneron
|
| 6/11/2015 | SP | New Issue: JPMorgan prices $3.26 million capped return enhanced notes on S&P 500
|
| 5/20/2015 | SP | New Issue: CIBC prices $397,000 contingent coupon autocallables on Regeneron
|
| 3/30/2015 | SP | New Issue: JPMorgan prices $8 million 10% autocallable reverse exchangeables on three pharma stocks
|
| 12/30/2014 | SP | New Issue: Barclays prices $7.84 million autocallable notes linked to three pharmaceutical stocks
|
| 12/29/2014 | SP | Barclays plans autocallable notes tied to three pharmaceutical stocks
|
| 11/24/2014 | SP | New Issue: RBC prices $50,000 8.5% reverse convertibles linked to Regeneron Pharmaceuticals
|
| 11/12/2014 | SP | New Issue: UBS prices $232,000 airbag phoenix autocallables linked to Regeneron Pharmaceuticals
|
| 11/7/2014 | SP | RBC to price 8.5% reverse convertibles linked to Regeneron Pharmaceuticals
|
| 11/5/2014 | SP | UBS plans to price airbag phoenix autocallables linked to Regeneron
|
| 10/30/2014 | SP | New Issue: RBC prices $27,000 8.35% reverse convertibles linked to Regeneron Pharmaceuticals
|
| 10/14/2014 | SP | RBC to price 7.15% reverse convertibles linked to Regeneron Pharmaceuticals
|
| 9/25/2014 | SP | New Issue: UBS prices $116,380 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 8/21/2014 | SP | RBC plans to price 8.75% reverse convertibles linked to Regeneron
|
| 8/20/2014 | SP | New Issue: RBC prices $80,000 9.25% reverse convertibles linked to Regeneron
|
| 8/8/2014 | SP | RBC to price 9.25% reverse convertibles linked to Regeneron
|
| 7/31/2014 | SP | New Issue: Morgan Stanley prices $2.36 million 7% airbag autocallables linked to Regeneron
|
| 7/30/2014 | SP | New Issue: RBC prices $597,000 9.5% reverse convertibles linked to Regeneron Pharmaceuticals
|
| 7/23/2014 | SP | Morgan Stanley plans 6%-7.25% airbag autocallables linked to Regeneron
|
| 7/22/2014 | SP | RBC to price 9.5% reverse convertibles linked to Regeneron Pharmaceuticals
|
| 7/22/2014 | SP | New Issue: UBS prices $208,000 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 6/23/2014 | SP | New Issue: UBS prices $666,500 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 5/29/2014 | SP | New Issue: Barclays prices $1 million 12.5% autocallable notes on three securities
|
| 5/15/2014 | SP | Barclays to price one-year autocallable notes linked to three stocks
|
| 4/23/2014 | SP | New Issue: UBS prices $265,195 8.49% trigger yield optimization notes linked to Regeneron Pharmaceuticals
|
| 2/26/2014 | SP | New Issue: UBS prices $200,000 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 2/25/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 1/23/2014 | SP | New Issue: UBS prices $158,650 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 12/11/2013 | SP | New Issue: UBS prices $359,000 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 12/3/2013 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 11/22/2013 | SP | New Issue: UBS prices $99,851 8.16% trigger yield optimization notes linked to Regeneron
|
| 11/5/2013 | SP | New Issue: UBS prices $113,000 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 10/29/2013 | SP | New Issue: UBS prices $99,789 11.75% trigger yield optimization notes linked to Regeneron Pharmaceuticals
|
| 10/28/2013 | SP | New Issue: UBS prices $99,687 8.65% trigger yield optimization notes linked to Regeneron Pharmaceuticals
|
| 10/28/2013 | SP | New Issue: UBS prices $294,819 11.96% trigger yield optimization notes linked to Regeneron Pharmaceuticals
|
| 10/22/2013 | SP | New Issue: JPMorgan prices $3.09 million 10.5% airbag autocallables linked to Regeneron
|
| 10/16/2013 | SP | JPMorgan to price 9%-11.25% airbag autocallables linked to Regeneron
|
| 10/16/2013 | SP | New Issue: UBS prices $129,790 11.23% trigger yield optimization notes linked to Regeneron Pharmaceuticals
|
| 10/11/2013 | SP | New Issue: UBS prices $171,100 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 9/11/2013 | SP | New Issue: UBS prices $345,000 airbag yield optimization notes linked to Regeneron Pharmaceuticals
|
| 8/27/2013 | SP | New Issue: UBS prices $608,209 9.58% trigger yield optimization notes linked to Regeneron Pharmaceuticals
|
| 8/15/2013 | SP | New Issue: UBS prices $100,000 airbag yield optimization notes linked to Regeneron Pharmaceuticals
|
| 8/15/2013 | SP | New Issue: UBS prices $165,000 trigger phoenix autocallable optimization securities linked to Regeneron Pharmaceuticals
|
| 7/16/2013 | SP | New Issue: Morgan Stanley prices $2.96 million 10.72% airbag autocallable notes linked to Regeneron
|
| 6/28/2013 | SP | New Issue: RBC prices $600,000 11.65% reverse convertibles linked to Regeneron Pharmaceuticals
|
